about the author

Josh Sullivan

josh@endpointsnews.com

author articles

BioN­Tech ex­pands mR­NA man­u­fac­tur­ing to Sin­ga­pore as clam­or for Covid-19 vac­cine and boost­ers swells

4 years ago
Manufacturing

An­oth­er failed tri­al for Or­p­hazyme's 'pipeline-in-a-pro­duc­t' leaves shad­ow on drug's fu­ture

5 years ago
R&D

Q&A: Ain­drea Camp­bell goes small, step­ping away from Ap­ple to head man­u­fac­tur­ing at Zymer­gen — where am­bi­tions are ...

5 years ago
People
Outsourcing

Lon­za keeps adding on as it looks to beef up bi­o­log­ics of­fer­ing, tack­ing on near­ly $1B in ex­pan­sions in EU, US

5 years ago
Outsourcing
Manufacturing

An­oth­er Mod­er­na ex­pan­sion is an­nounced, this time at its Mass­a­chu­setts site

5 years ago
Manufacturing

Covid-19 roundup: Pfiz­er/BioN­Tech do­nate their vac­cine to the Tokyo Olympics; No­vavax, Pfiz­er/BioN­Tech vac­cines ...

5 years ago
Coronavirus

Re­call re­port: Acel­la pulls thy­roid tablets af­ter a raft of side ef­fect re­ports; mis­la­bel­ing caus­es Pfiz­er's Hos­pi­ra ...

5 years ago
FDA+
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Freez­er kits to store vac­cines de­liv­ered to Venezuela; UN chief weighs in on IP ...

5 years ago
Outsourcing
Coronavirus

Al­ta­sciences, true to its word, ex­pands its foot­print with ac­qui­si­tion of Penn­syl­va­nia CRO

5 years ago
Deals
Manufacturing

Fo­cused on the cell ther­a­py man­u­fac­tur­ing bot­tle­neck, Cel­lares tur­bocharges plans for 'shut­tle' tech

5 years ago
Financing
Cell/Gene Tx

Se­quenc­ing up­start rais­es $273M ahead of IPO; Ac­er­a­gen ac­quires high­ly-an­tic­i­pat­ed Far­ber dis­ease treat­ment

5 years ago
News Briefing

Covid-19 roundup: EMA be­gins rolling re­view of first Chi­nese vac­cine; Af­ter 100% ef­fi­ca­cy tri­al, teenagers could be ...

5 years ago
Coronavirus

News brief­ing: Gy­ro­scope and Ta­laris set IPO terms; FDA grants ex­pand­ed nod to Chiesi's sick­le cell drug

5 years ago
News Briefing

Covid-19 roundup: No­vavax plots EU vac­cine ship­ments by end of year — re­port; Pfiz­er pledges med­i­cines, equip­ment ...

5 years ago
Coronavirus

Bio­gen won’t ex­plain why FDA slapped down their bid for new Tysabri for­mu­la­tion

5 years ago
Pharma
FDA+

Emer­gent reshuf­fles its man­u­fac­tur­ing brain trust as CEO sends mixed mes­sages around Covid-19 vac­cine de­ba­cle

5 years ago
Coronavirus
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Catal­ent adds freez­er part­ner for vac­cine pro­duc­tion push; In need of vol­un­teers, ...

5 years ago
Coronavirus
Manufacturing

AskBio bails on in-li­censed gene ther­a­py pro­gram af­ter find­ing is­sues with 3rd-par­ty man­u­fac­tur­er

5 years ago
R&D
Manufacturing

Sam­sung Bi­o­log­ics, TG Ther­a­peu­tics ink deal to mass pro­duce MS hope­ful ubli­tux­imab

5 years ago
Outsourcing
Manufacturing

Ther­mo Fish­er has flour­ished amid the pan­dem­ic, but can it keep the ball rolling when Covid-19 comes to a close?

5 years ago
Outsourcing
Manufacturing

Sanofi is ex­pand­ing at light speed abroad, but it's leav­ing be­hind a Penn­syl­va­nia plant and its 75 em­ploy­ees

5 years ago
Pharma
Manufacturing

Forge Bi­o­log­ics bags $120M round as it looks to scale AAV man­u­fac­tur­ing for Krabbe dis­ease treat­ment

5 years ago
Financing
Manufacturing

Lon­za adds on small mol­e­cule fa­cil­i­ty at Visp site, adding new weight to its ex­pan­sion plans on the back of a big ...

5 years ago
Outsourcing
Manufacturing

Covid-19 roundup: Atea Phar­ma­ceu­ti­cals launch­es an­tivi­ral in­to PhI­II tri­al; Cell­tri­on's an­ti­body shows promise ...

5 years ago
Coronavirus
First page Previous page 23242526272829 Next page Last page
A service from the Financial Times